To begin our investigation of whether the inflammatory cytokine, IL-1β, promoted an invasive phenotype in RCC, we first measured whether or not IL-1β treatment induced collagen invasion of the human 786-0 VHL null RCC cell line. This evidence concerns the gene VHL and renal cell carcinoma.